As of 2025-07-11, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (33.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1014.9%.
The range of the Relative Valuation is (32.16) - (32.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 18.6x | 18.4x |
| Forward P/E multiples | 18.2x - 20.7x | 19.4x |
| Fair Price | (32.16) - (32.86) | (33.39) |
| Upside | -981.0% - -1000.4% | -1014.9% |
| Date | P/E |